NEW YORK, May 12, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Generic Growth Strategies – Manufacturers to Increase Focus on
Super Generics and Biosimilars to Drive Revenues
http://www.reportlinker.com/p0491876/Generic-Growth-Strategies—Manufacturers-to-Increase-Focus-on-Super-Generics-and-Biosimilars-to-Drive-Revenues.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Vitamin_and_Supplement
Generic Growth Strategies – Manufacturers to Increase Focus on
Super Generics and Biosimilars to Drive Revenues
Summary
GBI Research has released its research “Generic Growth
Strategies – Manufacturers to Increase Focus on Super Generics and
Biosimilars to Drive Revenues”. It provides a comprehensive
overview of the generic drugs market, analysis of upcoming
noteworthy patent expirations, and trends and issues facing the
generics market. The report delves into much detail on the current
landscape; changes that have structured the generic drugs market in
the last 30 years; and the reason behind the players’ urgency in
developing and implementing generic growth strategies. The report
also contains impact analysis of the regulatory landscape in the
major geographies pertaining to the generic drugs market. Major
strategies adopted by the leading companies in the generic drugs
market have been analyzed in much detail, along with an elaborate
company portfolio and strategic
‘/>”/>
SOURCE